CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
Jung-A Yun, Hee Cheol Kim, Hyun-Sook Son, Hyoung Ran Kim, Hae Ran Yun, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun
Ann Coloproctol. 2010;26(4):287-292.   Published online August 31, 2010
DOI: https://doi.org/10.3393/jksc.2010.26.4.287

Excel Download

Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
Journal of the Korean Society of Coloproctology. 2010;26(4):287   Crossref logo
Link1

Cessation or dose reduction of Capecitabine due to Complications in Patients with Colon Cancer
Journal of the Korean Society of Coloproctology. 2010;26(4):240   Crossref logo
Link1

Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
British Journal of Cancer. 2010;104(1):43-50   Crossref logo
Link1 Link2 Link3

Oncologic outcome of Immediate Breast Reconstruction after mastectomy in breast cancer patients: A Systematic reviews and Meta-Analysis
European Journal of Cancer. 2022;175:S13   Crossref logo
Link1 Link2

Prognostic significance of tumour location to the oncologic outcome of colon cancer
Annals of Oncology. 2019;30:ix36-ix37   Crossref logo
Link1 Link2 Link3 Link4

Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine
Clinical Colorectal Cancer. 2017;16(3):e141-e145   Crossref logo
Link1 Link2

634 POSTER Post-study treatment does not influence outcome in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer
European Journal of Cancer Supplements. 2005;3(2):179   Crossref logo
Link1 Link2

PCN29 HRQOL During Adjuvant Chemotherapy With Capecitabine in Patients After Surgery for Colon Cancer: Additional Study of JFMC37-0801
Value in Health. 2012;15(7):A658   Crossref logo
Link1 Link2

Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer
Annals of Oncology. 2012;23(4):911-918   Crossref logo
Link1 Link2 Link3

Oncologic outcomes after resection of para-aortic lymph node metastasis in left-sided colon and rectal cancer
. 2020;   Crossref logo
Link1 Link2